BioStar Capital

A venture capital firm focused on transformative medical technologies.

Venture Capital Active Charlevoix, United States Est. 2005
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—

About

BioStar Capital is a venture capital firm founded in 2005 by Dr. Louis A. Cannon, a nationally recognized leader in cardiology. The firm is uniquely structured to focus on transformative medical technologies, with a team composed of healthcare clinicians, executives, medical thought leaders, and financial professionals. BioStar Capital manages five venture capital funds and primarily invests in early- and late-stage companies in cardiology, orthopedics, and robotics. Their mission is to improve patients' lives while providing returns for investors.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

2 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences4

Q&A

What is BioStar Capital's primary investment focus by sector?
BioStar Capital primarily focuses on the Health Tech & Life Sciences sector, with all four of its portfolio companies operating in this area.
Can you name some of BioStar Capital's notable exits?
BioStar Capital has seen two significant exits recently: CathWorks was acquired by Medtronic for $585M in February 2026, and V-Wave was acquired by Johnson & Johnson for $600M in August 2024.
Which portfolio companies has BioStar Capital invested in?
BioStar Capital's portfolio includes companies such as Angioslide, which develops embolic capture angioplasty devices, and CathWorks, known for noninvasive FFR measurements for coronary interventions.
What was the most recent exit for BioStar Capital?
BioStar Capital's most recent exit was CathWorks, which was acquired by Medtronic for $585M in February 2026.
What was the acquisition value for V-Wave, a BioStar Capital portfolio company?
V-Wave, a BioStar Capital portfolio company, was acquired by Johnson & Johnson for $600M in August 2024.
What is the typical investment range for BioStar Capital?
BioStar Capital's investment range is between $2M and $28M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2005